Philips extends AI portfolio with launch of IntelliSpace AI Workflow Suite to seamlessly integrate applications across imaging workflows

飞利浦推出IntelliSpace AI Workflow Suite产品组合,提高医疗保健解决方案

2019-12-02 08:30:00 GlobeNewswire


Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of IntelliSpace AI Workflow Suite [1] to enable healthcare providers to seamlessly integrate AI applications into the imaging workflow. Part of Philips’ new enterprise imaging informatics solution, the comprehensive AI workflow platform provides a full suite of applications for integration and centralized workflow management of AI algorithms, delivering structured results wherever they’re needed across the healthcare enterprise. Partners at launch include Aidoc, MaxQ AI, Quibim [2], Riverain Technologies and Zebra Medical. IntelliSpace AI Workflow Suite is being unveiled at the 2019 Radiological Society of North America Annual Meeting (RSNA). Leiden University Medical Center (LUMC) in the Netherlands recently signed an agreement to be the first healthcare provider to install the platform. A comprehensive solution that seamlessly integrates with existing workflowsIntegrating into existing department and hospital infrastructure, the suite automatically orchestrates the routing of clinical data to the appropriate AI application within the healthcare provider’s ecosystem to allow data analysis without user interaction, and displays the results. The suite is designed to support Philips’ commitment to providing open, comprehensive solutions to healthcare providers’ AI imaging needs. Natively integrating with Philips’ diagnostic imaging and informatics solutions, IntelliSpace AI Workflow Suite can also be used alongside imaging solutions from other vendors. In addition, the suite is designed to support the training of site-specific AI applications based on local data. Philips recognized for AI leadershipPhilips was recently recognized by Frost & Sullivan as Company of the Year for Artificial Intelligence for Enhanced Radiology Interpretation, thanks to the company’s approach to imaging AI as a disruptive imaging informatics strategy. Recognized for AI combining with deep knowledge of the clinical and operational context in which it is used, Philips is embedding AI within imaging workflows across multiple touchpoints to better personalize the patient care pathway. “AI is already supporting clinical decision-making and increasing efficiency in imaging departments,” said Calum Cunningham, General Manager Enterprise Diagnostic Informatics at Philips. “Philips is among the top three companies in the world in terms of AI-related patent applications in healthcare. With the IntelliSpace AI Workflow Suite we’re enabling healthcare providers to take a comprehensive, future-proof approach to integrating AI applications that maximizes their benefits while ensuring seamless integration into existing workflows.” AI-enabled imaging applications and AI algorithms are playing an important role in achieving the ‘quadruple aim’ in healthcare: better health outcomes, lower cost of care, and an improved experience for patients and staff. As the number of applications and vendors increases, healthcare providers risk being overwhelmed by technical integration challenges as well as administrative overhead. By seamlessly integrating AI applications from Philips’ partners, the Philips IntelliSpace AI Workflow Suite enables healthcare providers to capitalize on the latest AI applications, increase diagnostic confidence and efficiency without adding complexity. Philips IntelliSpace AI Workflow Suite is launching with applications including: Part of Philips’ next-generation enterprise imaging informatics solution IntelliSpace AI Workflow Suite is part of Philips’ next-generation enterprise imaging informatics solution. The introduction follows several years of strategic investments in R&D, AI and complementary acquisitions, resulting in a suite of integrated products that deliver a comprehensive platform designed to connect clinical capabilities and optimize workflows around every step in the patient’s journey. Philips is demonstrating its imaging solutions at the 2019 Radiological Society of North America (RSNA) Annual Meeting in booth #6730. In addition to its main presence (booth #6730), Philips will also have a strong presence in the AI Showcase hall (North Hall Level 1, booth #10109). For more information about Philips’ presence at RSNA, including its program of live talks on a range of topics including AI in radiology, visit, and follow @PhilipsLiveFrom for #RSNA19 live updates. [1] IntelliSpace AI Workflow Suite is not intended for diagnosis or treatment selection. Work in progress, not available for sale.[2] Applications from Quibim are not 510(k) cleared and not available for sale in the USA. For further information, please contact: Mark GrovesPhilips Global Press OfficeTel.: +31 631 639 916Email: mark.groves@philips.comTwitter: @mark_groves About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 80,000 employees with sales and services in more than 100 countries. News about Philips can be found at   Attachment
皇家飞利浦( NYSE : PHG , AEX : PHIA ),全球卫生技术领导者,今天宣布推出 IntelliSpace AI Workflow Suite [1],使医疗保健供应商能够无缝地将人工智能应用程序集成到成像工作流程中。作为飞利浦新的企业成像信息化解决方案的一部分,综合 AI 工作流平台提供了一套完整的应用程序,用于人工智能算法的集成和集中式工作流管理,在医疗保健企业需要的任何地方提供结构化结果。推出的合作伙伴包括 Aidoc 、 MaxQ AI 、 Quibim [2]、 Riverain Technologies 和 Zebra Medical 。 智能空间 AI 工作流程套件将在2019年北美放射学会年会( RSNA )上发布。荷兰莱顿大学医学中心( LUMC )最近签署了一项协议,成为第一家安装该平台的医疗保健供应商。 与现有工作流程无缝集成的全面解决方案集成到现有的部门和医院基础架构中,该套件自动将临床数据路由安排到医疗保健提供商生态系统中的适当 AI 应用程序,以允许数据分析而无需用户交互。并显示结果。该套件旨在支持飞利浦致力于为医疗保健提供商的人工智能成像需求提供开放、全面的解决方案。IntelliSpace AI Workflow Suite 在本地集成了飞利浦的诊断成像和信息学解决方案,还可以与其他供应商的成像解决方案一起使用。此外,该套件旨在支持基于本地数据的特定现场人工智能应用程序的培训。 飞利浦认可的人工智能领导者飞利浦最近被 Frost & Sullivan 认可为增强放射学解释人工智能年度公司,这得益于该公司将成像 AI 作为破坏性成像信息学战略的做法。被认可的人工智能结合临床和操作环境的深入知识,在成像工作流程中通过多个接触点嵌入人工智能,以更好地个性化患者护理路径。 “人工智能已经在支持临床决策,提高成像部门的效率,”飞利浦企业诊断信息部门总经理 Calum Cunningham 说。“就医疗领域人工智能相关专利申请而言,飞利浦是全球前三大公司之一。借助 IntelliSpace AI Workflow Suite ,我们使医疗保健提供商能够采取全面的、未来可证明的方法,集成人工智能应用程序,最大限度地提高其效益,同时确保无缝集成到现有工作流程中。” 支持人工智能的成像应用程序和人工智能算法在实现医疗保健的“四倍目标”方面发挥了重要作用:更好的健康结果、更低的护理成本以及改善患者和员工的体验。随着应用程序和供应商数量的增加,医疗保健提供商面临着技术集成挑战和管理开销的压力。通过无缝集成来自飞利浦合作伙伴的人工智能应用程序,飞利浦智能空间 AI 工作流套件使医疗服务提供商能够利用最新的人工智能应用程序,在不增加复杂性的情况下提高诊断信心和效率。 飞利浦 IntelliSpace AI Workflow Suite 正在推出应用程序,包括: 飞利浦下一代企业成像信息解决方案 IntelSpace AI Workflow Suite 的一部分是飞利浦下一代企业成像信息解决方案的一部分。在介绍之前,在研发、人工智能和补充性收购方面进行了多年的战略投资,形成了一套集成产品,提供了一个全面的平台,旨在连接临床能力,并优化患者旅途中每一步的工作流程。 飞利浦在2019年北美放射学会年会( RSNA )第6730号展台上展示其成像解决方案。除了它的主要存在(展位#6730),飞利浦也将有一个强大的存在在 AI 展厅(北厅一级,展位#10109)。有关飞利浦在 RSNA 的存在的更多信息,包括关于放射医学人工智能等一系列主题的现场讲座,请访问 / RSNA ,并按照@ PhilippsLiveFrofrom 获取# RSNA19实时更新。 [1] IntelliSpace AI Workflow Suite 不适用于诊断或治疗选择。正在进行中的工作,不能出售。[2] Quibim 的申请没有得到批准,也不能在美国销售。 详情请联络: Mark GrovesPhilips 全球新闻办公室电话.:+31631639916电子邮件:标记。groves @ philips.comTwitter :@ mark _ groves 关于皇家飞利浦 皇家飞利浦公司( NYSE : PHG , AEX : PHIA )是一家领先的健康技术公司,致力于改善人们的健康状况,并在从健康生活和预防到诊断、治疗和家庭护理的整个健康过程中实现更好的结果。飞利浦利用先进的技术和深入的临床和消费者洞察力,提供综合解决方案。公司总部位于荷兰,是诊断成像、影像引导治疗、患者监测和健康信息学以及消费者健康和家庭护理领域的领导者。飞利浦2018年销售额为181亿欧元,在100多个国家拥有约8万名员工,销售和服务。有关飞利浦的新闻,请访问:\160; / newcenter 。 附件